Value Adjusted for Debt and Cash: Vor Bio Inc. (VOR)

Vor Biopharma Inc. (VOR) operations involve colossal cell engineering costs and uncertainty regarding clinical trial outcomes. At the same time, holding patents in gene editing for the protection of healthy tissues lays the foundation for long-term dominance. Due to the uniqueness of the therapy, the company will be able to exercise pricing power, which supports an Enterprise Value of 758.45. This price action reflects the dynamics of this metric.

VOR Vor Biopharma Enterprise Value (11/23/2025 - 10/29/2026)

Vor Biopharma Inc. (VOR) - metric breakdowns and financial figures

- market value and analyst target forecast:

Market Price Vor Biopharma, Inc.|VOR - Price Target Chart

- company stock exchange capitalization indicators:

Market Value Vor Biopharma|VOR - Enterprise Value

- book capitalization information:

Accounting Value per Share Vor Biopharma|VOR - Book Capitalization|Market Capitalization to Book Value Ratio vorbio.com|VOR - Aggregate Company Assets

- business debt structure and liquidity details:

- earnings and multiples data:

VOR - Net Profit

Summary company analytics:Vor Biopharma Inc.

The scale of Vor Biopharma Inc. (VOR) high-tech facilities in Massachusetts and the costs of maintaining sterile zones are reflected in the historical enterprise value trend. This metric aggregates market capitalization and net debt to determine the actual cost of acquiring the business, allowing investors to differentiate organic valuation growth from the risky borrowing of capital used to develop biolabs.

Competitors of Vor Biopharma Inc. (VOR)